Evidence-informed management of chronic low back pain with trigger point injections

Spine Journal

Volumn 8, Issue 1, 2008, Pages 243-252

  Malanga, Gerard ^a,b,c   Wolff, Erin ^b,c,d  

^a Overlook Pain Center   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c OVERLOOK HOSPITAL   (United States)

^d Atlantic Health   (United States)

Author keywords

Chronic low back pain; Injection; Myofascial pain syndrome; Trigger points (TrPs)

Indexed keywords

2 PROPANOL; ARACHIS OIL; BOTULINUM TOXIN A; BUPIVACAINE; CAMPHOR; CORTICOSTEROID; DEXAMETHASONE; LIDOCAINE; LOCAL ANESTHETIC AGENT; NALOXONE; POVIDONE IODINE; PROCAINE; ROPIVACAINE; SALICYLIC ACID BENZYL ESTER; TETRACAINE;

ABSCESS; CHRONIC PAIN; DECISION MAKING; DISPOSABLE EQUIPMENT; ELECTROMYOGRAPHY; EPIDURAL ABSCESS; EVIDENCE BASED MEDICINE; EVIDENCE INFORMED MANAGEMENT; FLU LIKE SYNDROME; GATE CONTROL THEORY; HEALTH CARE COST; HEALTH INSURANCE; HEMATOMA; HISTORY OF MEDICINE; HUMAN; INJECTION SITE; INJECTION SITE PAIN; LOW BACK PAIN; MUSCLE WEAKNESS; MYOFASCIAL PAIN; NONHUMAN; PARESTHESIA; PATIENT CODING; PHYSICIAN; PNEUMOTHORAX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REIMBURSEMENT; REVIEW; SKELETAL MUSCLE; SPINAL CORD; SYRINGE; SYSTEMATIC REVIEW; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TRIGGER POINT;

ANALGESICS; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; INJECTIONS, INTRAMUSCULAR; LOW BACK PAIN; MYOFASCIAL PAIN SYNDROMES;

EID: 37449015428     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2007.10.029     Document Type: Review

References (105)

1. Fricton J.R., Auvinen M.D., Dykstra D., and Schiffman E. Myofascial pain syndrome: electromyographic changes associated with local twitch response. Arch Phys Med Rehabil 66 (1985) 314-317
2. Bronfort G., Nilsson N., Haas M., et al. Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev (2004) CD001878
3. David G. Travell & Simons' myofascial pain and dysfunction: the trigger point manual (1999), Williams & Wilkins
4. Simons D.G. Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction. J Electromyogr Kinesiol 14 (2004) 95-107
5. Kilkenny M.B., Deane K., Smith K.A., and Eyre S. Non-invasive physical treatments of myofascial pain. Cochrane Database Syst Rev (2006)
6. Gerwin R.D., Shannon S., Hong C.Z., Hubbard D., and Gevirtz R. Interrater reliability in myofascial trigger point examination. Pain 69 (1997) 65-73
7. Magni G., Caldieron C., Rigatti-Luchini S., and Merskey H. Chronic musculoskeletal pain and depressive symptoms in the general population. An analysis of the 1st National Health and Nutrition Examination Survey data. Pain 43 (1990) 299-307
8. Finlay J.E. Myofascial pain. [Internet] Available at: (March 22, 2006). www.eMedicine.com
9. Wolfe F., Simons D.G., Fricton J., et al. The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease. J Rheumatol 19 (1992) 944-951
10. Graboski C.L., Gray D.S., and Burnham R.S. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study. Pain 118 (2005) 170-175
11. Iwama H., Ohmori S., Kaneko T., and Watanabe K. Water-diluted local anesthetic for trigger-point injection in chronic myofascial pain syndrome: evaluation of types of local anesthetic and concentrations in water. Reg Anesth Pain Med 26 (2001) 333-336
12. Krishnan S.K., Benzon H.T., Siddiqui T., and Canlas B. Pain on intramuscular injection of bupivacaine, ropivacaine, with and without dexamethasone. Reg Anesth Pain Med 25 (2000) 615-619
13. Iwama H., and Akama Y. The superiority of water-diluted 0.25% to neat 1% lidocaine for trigger-point injections in myofascial pain syndrome: a prospective, randomized, double-blinded trial. Anesth Analg 91 (2000) 408-409
14. Hong C.Z. Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response. Am J Phys Med Rehabil 73 (1994) 256-263
15. Garvey T.A., Marks M.R., and Wiesel S.W. A prospective, randomized, double-blind evaluation of trigger-point injection therapy for low-back pain. Spine 14 (1989) 962-964
16. Frost A. Diclofenac versus lidocaine as injection therapy in myofascial pain. Scand J Rheumatol 15 (1986) 153-156
17. Hameroff S.R., Crago B.R., Blitt C.D., Womble J., and Kanel J. Comparison of bupivacaine, etidocaine, and saline for trigger-point therapy. Anesth Analg 60 (1981) 752-755
18. Frost F.A., Jessen B., and Siggaard-Andersen J. A control, double-blind comparison of mepivacaine injection versus saline injection for myofascial pain. Lancet 1 (1980) 499-500
19. Esenyel M., Caglar N., and Aldemir T. Treatment of myofascial pain. Am J Phys Med Rehabil 79 (2000) 48-52
20. Kamanli A., Kaya A., Ardicoglu O., Ozgocmen S., Zengin F.O., and Bayik Y. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 25 (2005) 604-611
21. McMillan A.S., Nolan A., and Kelly P.J. The efficacy of dry needling and procaine in the treatment of myofascial pain in the jaw muscles. J Orofac Pain 11 (1997) 307-314
22. Tschopp K.P., and Gysin C. Local injection therapy in 107 patients with myofascial pain syndrome of the head and neck. ORL J Otorhinolaryngol Relat Spec 58 (1996) 306-310
23. Ferrante F.M., Bearn L., Rothrock R., and King L. Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A. Anesthesiology 103 (2005) 377-383
24. Cheshire W.P., Abashian S.W., and Mann J.D. Botulinum toxin in the treatment of myofascial pain syndrome. Pain 59 (1994) 65-69
25. Qerama E., Fuglsang-Frederiksen A., Kasch H., Bach F.W., and Jensen T.S. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. Neurology 67 (2006) 241-245
26. Ojala T., Arokoski J.P., and Partanen J. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial. Clin J Pain 22 (2006) 90-96
27. Wheeler A.H., Goolkasian P., and Gretz S.S. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine 23 (1998) 1662-1666
28. Peloso P., Gross A., Haines T., Trinh K., Goldsmith C.H., and Aker P. Medicinal and injection therapies for mechanical neck disorders. Cochrane Database Syst Rev (2005)
29. Freund B.J., and Schwartz M. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study. J Rheumatol 27 (2000) 481-484
30. Schnider P., Moraru E., Vigl M., et al. Physical therapy and adjunctive botulinum toxin type A in the treatment of cervical headache: a double-blind, randomised, placebo-controlled study. J Headache Pain 3 (2002) 93-99
31. Wheeler A.H., Goolkasian P., and Gretz S.S. Botulinum toxin A for the treatment of chronic neck pain. Pain 94 (2001) 255-260
32. Ettlin T. Trigger point injection treatment with the 5-HT3 receptor antagonist tropisetron in patients with late whiplash-associated disorder. First results of a multiple case study. Scand J Rheumatol Suppl 119 (2004) 49-50
33. Muller W., and Stratz T. Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron. Scand J Rheumatol Suppl 119 (2004) 44-48
34. Hesse J., Mogelvang B., and Simonsen H. Acupuncture versus metoprolol in migraine prophylaxis: a randomized trial of trigger point inactivation. J Intern Med 235 (1994) 451-456
35. Hong C.Z., Kuan T.S., Chen J.T., and Chen S.M. Referred pain elicited by palpation and by needling of myofascial trigger points: a comparison. Arch Phys Med Rehabil 78 (1997) 957-960
36. Itoh K., Katsumi Y., and Kitakoji H. Trigger point acupuncture treatment of chronic low back pain in elderly patients-a blinded RCT. Acupunct Med 22 (2004) 170-177
37. Irnich D., Behrens N., Gleditsch J.M., et al. Immediate effects of dry needling and acupuncture at distant points in chronic neck pain: results of a randomized, double-blind, sham-controlled crossover trial. Pain 99 (2002) 83-89
38. Chen J.T., Chung K.C., Hou C.R., Kuan T.S., Chen S.M., and Hong C.Z. Inhibitory effect of dry needling on the spontaneous electrical activity recorded from myofascial trigger spots of rabbit skeletal muscle. Am J Phys Med Rehabil 80 (2001) 729-735
39. Itoh K., Katsumi Y., Hirota S., and Kitakoji H. Effects of trigger point acupuncture on chronic low back pain in elderly patients-a sham-controlled randomised trial. Acupunct Med 24 (2006) 5-12
40. Hanten W.P., Olson S.L., Butts N.L., and Nowicki A.L. Effectiveness of a home program of ischemic pressure followed by sustained stretch for treatment of myofascial trigger points. Phys Ther 80 (2000) 997-1003
41. Cohen J.H., Gibbons R.W., and Raymond L. Nimmo and the evolution of trigger point therapy, 1929-1986. J Manipulative Physiol Ther 21 (1998) 167-172
42. Hou C.R., Tsai L.C., Cheng K.F., Chung K.C., and Hong C.Z. Immediate effects of various physical therapeutic modalities on cervical myofascial pain and trigger-point sensitivity. Arch Phys Med Rehabil 83 (2002) 1406-1414
43. Majlesi J., and Unalan H. High-power pain threshold ultrasound technique in the treatment of active myofascial trigger points: a randomized, double-blind, case-control study. Arch Phys Med Rehabil 85 (2004) 833-836
44. Kovacs F.M., Abraira V., Pozo F., et al. Local and remote sustained trigger point therapy for exacerbations of chronic low back pain. A randomized, double-blind, controlled, multicenter trial. Spine 22 (1997) 786-797
45. Hsueh T.C., Cheng P.T., Kuan T.S., and Hong C.Z. The immediate effectiveness of electrical nerve stimulation and electrical muscle stimulation on myofascial trigger points. Am J Phys Med Rehabil 76 (1997) 471-476
46. Graff-Radford S.B., Reeves J.L., Baker R.L., and Chiu D. Effects of transcutaneous electrical nerve stimulation on myofascial pain and trigger point sensitivity. Pain 37 (1989) 1-5
47. Chee E.K., and Walton H. Treatment of trigger points with microamperage transcutaneous electrical nerve stimulation (TENS)-(the Electro-Acuscope 80). J Manipulative Physiol Ther 9 (1986) 131-134
48. Yokoyama M., Sun X., Oku S., et al. Comparison of percutaneous electrical nerve stimulation with transcutaneous electrical nerve stimulation for long-term pain relief in patients with chronic low back pain. Anesth Analg 98 (2004) 1552-1556 table
49. Weiner D.K., Rudy T.E., Glick R.M., et al. Efficacy of percutaneous electrical nerve stimulation for the treatment of chronic low back pain in older adults. J Am Geriatr Soc 51 (2003) 599-608
50. Ghoname E.S., Craig W.F., White P.F., et al. The effect of stimulus frequency on the analgesic response to percutaneous electrical nerve stimulation in patients with chronic low back pain. Anesth Analg 88 (1999) 841-846
51. Ghoname E.A., Craig W.F., White P.F., et al. Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study. JAMA 281 (1999) 818-823
52. Snyder-Mackler L., Barry A.J., Perkins A.I., and Soucek M.D. Effects of helium-neon laser irradiation on skin resistance and pain in patients with trigger points in the neck or back. Phys Ther 69 (1989) 336-341
53. Olavi A., Pekka R., Pertti K., and Pekka P. Effects of the infrared laser therapy at treated and non-treated trigger points. Acupunct Electrother Res 14 (1989) 9-14
54. Bohr T.W. Fibromyalgia syndrome and myofascial pain syndrome. Do they exist?. Neurol Clin 13 (1995) 365-384
55. Wolfe F., Smythe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33 (1990) 160-172
56. Travell J.G., and Simons D.G. Myofascial pain and dysfunction: the trigger point manual (1983), Williams & Wilkins, Baltimore 276-277
57. McPartland J.M. Travell trigger points-molecular and osteopathic perspectives. J Am Osteopath Assoc 104 (2004) 244-249
58. Sola A.E., and Kuitert J.H. Myofascial trigger point pain in the neck and shoulder girdle; report of 100 cases treated by injection of normal saline. Northwest Med 54 (1955) 980-984
59. Delaney G.A., and McKee A.C. Inter- and intra-rater reliability of the pressure threshold meter in measurement of myofascial trigger point sensitivity. Am J Phys Med Rehabil 72 (1993) 136-139
60. Sciotti V.M., Mittak V.L., DiMarco L., et al. Clinical precision of myofascial trigger point location in the trapezius muscle. Pain 93 (2001) 259-266
61. Hong C.Z., and Hsueh T.C. Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia. Arch Phys Med Rehabil 77 (1996) 1161-1166
62. Cooper A.L. Trigger-point injection: its place in physical medicine. Arch Phys Med Rehabil 42 (1961) 704-709
63. Simons D.G., and Dommerholt J. Myofascial pain syndromes- Trigger points (literature reviews). J Musculoskelet Pain 13 (2005) 51-62
64. Simons D.G., and Dommerholt J. Myofascial pain syndromes- Trigger points (literature reviews). J Musculoskelet Pain 13 (2005) 53-64
65. American Medical Association. Healthcare Common Procedure Coding System. American Medical Association Healthcare Common Procedure Coding System Medicare's National Level II Codes HCPCS 2006. Available at: (May 1, 2006). https://www.oxhp.com/secure/policy/trigger_point_injections.html
66. American Medical Association. Article for trigger point injections-Coding Guidelines for LCD L19485. Centers for Medicare and Medicaid Services. Available at: (March 16, 2007). http://www.empiremedicare.com/newjpolicy/policy/l19485_final.htm
67. Le B.D., Dickenson A.H., and Besson J.M. Diffuse noxious inhibitory controls (DNIC). I., Effects on dorsal horn convergent neurones in the rat. Pain 6 (1979) 283-304
68. Byrn C., Olsson I., Falkheden L., et al. Subcutaneous sterile water injections for chronic neck and shoulder pain following whiplash injuries. Lancet 341 (1993) 449-452
69. Simons D.G., Hong C.Z., and Simons L.S. Spontaneous electrical activity of trigger points. J Musculoskelet Pain 3 (1995) 124
70. Simons D.G. Clinical and etiological update of myofascial pain from trigger points. J Musculoskelet Pain 4 (1996) 93-121
71. Kuan T.S., Chen J.T., Chen S.M., Chien C.H., and Hong C.Z. Effect of botulinum toxin on endplate noise in myofascial trigger spots of rabbit skeletal muscle. Am J Phys Med Rehabil 81 (2002) 512-520
72. Hong C.Z., and Simons D.G. Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points. Arch Phys Med Rehabil 79 (1998) 863-872
73. Melzack R. Myofascial trigger points: relation to acupuncture and mechanisms of pain. Arch Phys Med Rehabil 62 (1981) 114-117
74. Melzack R., and Wall P.D. Pain mechanisms: a new theory. Science 150 (1965) 971-979
75. Fine P.G., Milano R., and Hare B.D. The effects of myofascial trigger point injections are naloxone reversible. Pain 32 (1988) 15-20
76. Jaeger B., and Skootsky S.A. Double blind, controlled study of different myofascial trigger point injection techniques. Pain 4 (1987)
77. Simons D.G., Hong C.Z., and Simons L.S. Endplate potentials are common to midfiber myofacial trigger points. Am J Phys Med Rehabil 81 (2002) 212-222
78. Kao M.J., Hsieh Y.L., Kuo F.J., and Hong C.Z. Electrophysiological assessment of acupuncture points. Am J Phys Med Rehabil 85 (2006) 443-448
79. Chen J.T., Chen S.M., Kuan T.S., Chung K.C., and Hong C.Z. Phentolamine effect on the spontaneous electrical activity of active loci in a myofascial trigger spot of rabbit skeletal muscle. Arch Phys Med Rehabil 79 (1998) 790-794
80. Kruse Jr. R.A., and Christiansen J.A. Thermographic imaging of myofascial trigger points: a follow-up study. Arch Phys Med Rehabil 73 (1992) 819-823
81. Gerwin R.D., Dommerholt J., and Shah J.P. An expansion of Simons' integrated hypothesis of trigger point formation. Curr Pain Headache Rep 8 (2004) 468-475
82. Nice D.A., Riddle D.L., Lamb R.L., Mayhew T.P., and Rucker K. Intertester reliability of judgments of the presence of trigger points in patients with low back pain. Arch Phys Med Rehabil 73 (1992) 893-898
83. Hsieh C.Y., Hong C.Z., Adams A.H., et al. Interexaminer reliability of the palpation of trigger points in the trunk and lower limb muscles. Arch Phys Med Rehabil 81 (2000) 258-264
84. Al-Shenqiti A.M., and Oldham J.A. Test-retest reliability of myofascial trigger point detection in patients with rotator cuff tendonitis. Clin Rehabil 19 (2005) 482-487
85. Njoo K.H., and Van der D.E. The occurrence and inter-rater reliability of myofascial trigger points in the quadratus lumborum and gluteus medius: a prospective study in non-specific low back pain patients and controls in general practice. Pain 58 (1994) 317-323
86. Jaeger B., and Reeves J.L. Quantification of changes in myofascial trigger point sensitivity with the pressure algometer following passive stretch. Pain 27 (1986) 203-210
87. Fischer A.A. Pressure algometry over normal muscles. Standard values, validity and reproducibility of pressure threshold. Pain 30 (1987) 115-126
88. Fischer A.A. Documentation of myofascial trigger points. Arch Phys Med Rehabil 69 (1988) 286-291
89. Porta M., and Maggioni G. Botulinum toxin (BoNT) and back pain. J Neurol 251 (2004) I15-I18
90. Weiss B.D. Why is aspirin a contraindication for trigger-point injections?. Am Fam Physician 67 (2003) 32
91. Chu J., and Schwartz I. The muscle twitch in myofascial pain relief: effects of acupuncture and other needling methods. Electromyogr Clin Neurophysiol 42 (2002) 307-311
92. Staud R. Are tender point injections beneficial: the role of tonic nociception in fibromyalgia. Curr Pharm Des 12 (2006) 23-27
93. Reddy S.S., Yunus M.B., Inanici F., and Aldag J.C. Tender point injections are beneficial in fibromyalgia syndrome: a descriptive, open study. J Musculoskelet Pain 8 (2000) 7-18
94. Nelemans P.J., de Bie R., de Vet H.C., and Sturmans F. Injection therapy for subacute and chronic benign low-back pain. Cochrane Database Syst Rev (2006)
95. Furlan A.D., van Tulder M.W., Cherkin D.C., et al. Acupuncture and dry-needling for low back pain. Cochrane Database Syst Rev (2005) CD001351
96. Gunn C.C., Milbrandt W.E., Little A.S., and Mason K.E. Dry needling of muscle motor points for chronic low-back pain: a randomized clinical trial with long-term follow-up. Spine 5 (1980) 279-291
97. Shafer N. Pneumothorax following "trigger point" injection. JAMA 213 (1970) 1193
98. Elias M. Cervical epidural abscess following trigger point injection. J Pain Symptom Manage 9 (1994) 71-72
99. Hopwood M.B., and Abram S.E. Factors associated with failure of trigger point injections. Clin J Pain 10 (1994) 227-234
100. Airaksinen O., Brox J.I., Cedraschi C., et al. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 15 (2006) S192-S300
101. Adult low back pain. Institute for Clinical Systems Improvement. Available at: (March, 2007). http://www.guideline.gov/summary/summary.aspx?doc_id=9863&;nbr=00528 7&string=adult+AND+low+AND+back+AND+pain
102. Evidence Based Clinical Practice Guideline Working Group. Low Back Pain-Sciatica. Veterans Health Administration, Department of Veterans Affairs and Health Affairs, Department of Defense. Available at: (1999). http://www.oqp.med.va.gov
103. Back Pain-Lower. National Library for Health. Available at: (March, 2007). http://www.cks.library.nhs.uk/back_pain_lower/view_whole_guidance
104. Cummings T.M., and White A.R. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil 82 (2001) 986-992
105. Nelemans P.J., de Bie R.A., de Vet H.C., and Sturmans F. Injection therapy for subacute and chronic benign low back pain. Cochrane Database Syst Rev (2000) CD001824